Recent advances and novel treatment paradigms in acute lymphocytic leukemia

di Papadantonakis, Nikolaos, Advani, Anjali S.
Pubblicato in Ther Adv Hematol (2016)

Management of older adults with acute lymphoblastic leukemia: challenges & current approaches

di Sawalha, Yazeed, Advani, Anjali S
Pubblicato in Int J Hematol Oncol (2018)

Adult acute lymphocytic leukemia biology and treatment /

di Advani, Anjali S., Lazarus, Hillard M.
Pubblicazione 2011

Navigating the nexus of MRD and novel agents in ALL

di Advani, Anjali S., Copelan, Edward A.
Pubblicato in Hematology Am Soc Hematol Educ Program (2019)

Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia

di Portell, Craig A, Wenzell, Candice M, Advani, Anjali S
Pubblicazione 2013

Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukeaemia (OPAL): a randomized open-label phase 2 study

di Cortes, Jorge, Feldman, Eric, Yee, Karen, Rizzieri, David, Advani, Anjali S., Charman, Anthony, Spruyt, Richard, Toal, Martin, Kantarjian, Hagop
Pubblicato in Lancet Oncol (2013)

Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

di Sekeres, Mikkael A., Elson, Paul, Kalaycio, Matt E., Advani, Anjali S., Copelan, Edward A., Faderl, Stefan, Kantarjian, Hagop M., Estey, Elihu
Pubblicazione 2009

SWOG0919: A Phase 2 Study of Idarubicin and Cytarabine in Combination with Pravastatin for Relapsed Acute Myeloid Leukaemia

di Advani, Anjali S., McDonough, Shannon, Copelan, Edward, Willman, Cheryl, Mulford, Deborah A., List, Alan F., Sekeres, Mikkael A., Othus, Megan, Appelbaum, Frederick R.
Pubblicazione 2014

Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

di Advani, Anjali S, Gibson, Sarah E, Douglas, Elizabeth, Jin, Tao, Zhao, Xiaoxian, Kalaycio, Matt, Copelan, Ed, Sobecks, Ronald, Sekeres, Mikkael, Sungren, Shawnda, Hsi, Eric D
Pubblicazione 2010

SWOG S0910: A Phase 2 Trial of Clofarabine/Cytarabine/Epratuzumab for Relapsed/Refractory Acute Lymphocytic Leukaemia

di Advani, Anjali S., McDonough, Shannon, Coutre, Steven, Wood, Brent, Radich, Jerald, Mims, Martha, O’Donnell, Margaret, Elkins, Stephanie, Becker, Michael, Othus, Megan, Appelbaum, Frederick R.
Pubblicazione 2014

A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605

di Sekeres, Mikkael A., Gundacker, Holly, Lancet, Jeffrey, Advani, Anjali, Petersdorf, Stephen, Liesveld, Jane, Mulford, Deborah, Norwood, Tom, Willman, Cheryl L., Appelbaum, Frederick R., List, Alan F.
Pubblicazione 2011

Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies

di Statler, Abby, Othus, Megan, Erba, Harry P., Chauncey, Thomas R., Radich, Jerald P., Coutre, Steven, Advani, Anjali, Nand, Sucha, Ravandi, Farhad, Mukherjee, Sudipto, Sekeres, Mikkael A.
Pubblicato in Blood (2018)

Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline

di de Haas, Valérie, Ismaila, Nofisat, Advani, Anjali, Arber, Daniel A., Dabney, Raetasha S., Patel-Donnelly, Dipti, Kitlas, Elizabeth, Pieters, Rob, Pui, Ching-Hon, Sweet, Kendra, Zhang, Ling
Pubblicato in J Clin Oncol (2019)

Report of the Relapsed/Refractory Cohort of SWOG S0919: A Phase 2 Study of Idarubicin and Cytarabine in Combination with Pravastatin for Acute Myelogenous Leukemia (AML)

di Advani, Anjali S., Li, Hongli, Michaelis, Laura C., Medeiros, Bruno C., Liedtke, Michaela, List, Alan F., O’Dwyer, Kristen, Othus, Megan, Erba, Harry P., Appelbaum, Frederick R.
Pubblicato in Leuk Res (2018)

P53-INDEPENDENT, NORMAL STEM CELL SPARING EPIGENETIC-DIFFERENTIATION THERAPY FOR MYELOID AND OTHER MALIGNANCIES

di Saunthararajah, Yogen, Triozzi, Pierre, Rini, Brian, Singh, Arun, Radivoyevitch, Tomas, Sekeres, Mikkael, Advani, Anjali, Tiu, Ramon, Reu, Frederic, Kalaycio, Matt, Copelan, Ed, Hsi, Eric, Lichtin, Alan, Bolwell, Brian
Pubblicazione 2012

An inherited genetic variant in CEP72 promoter predisposes to vincristine-induced peripheral neuropathy in adults with acute lymphoblastic leukemia

di Stock, Wendy, Diouf, Barthelemy, Crews, Kristine R., Pei, Deqing, Cheng, Cheng, Laumann, Kristina, Mandrekar, Sumithra J., Luger, Selina, Advani, Anjali, Stone, Richard M., Larson, Richard A., Evans, William E.
Pubblicato in Clin Pharmacol Ther (2016)

Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms

di Visconte, Valeria, Przychodzen, Bartlomiej, Han, Yingchun, Nawrocki, Steffan T., Thota, Swapna, Kelly, Kevin R., Patel, Bhumika J., Hirsch, Cassandra, Advani, Anjali S., Carraway, Hetty E., Sekeres, Mikkael A., Maciejewski, Jaroslaw P., Carew, Jennifer S.
Pubblicato in Leukemia (2016)

A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia

di Kantarjian, Hagop M., Schuster, Michael W., Jain, Nitin, Advani, Anjali, Jabbour, Elias, Gamelin, Erick, Rasmussen, Erik, Juan, Gloria, Anderson, Abraham, Chow, Vincent F., Friberg, Gregory, Vogl, Florian D., Sekeres, Mikkael A.
Pubblicato in Am J Hematol (2017)

The novel autophagy inhibitor ROC-325 augments the anti-leukemic activity of azacitidine

di Nawrocki, Steffan T., Han, Yingchun, Visconte, Valeria, Przychodzen, Bartlomiej, Espitia, Claudia M., Phillips, James, Anwer, Faiz, Advani, Anjali, Carraway, Hetty E., Kelly, Kevin R., Sekeres, Mikkael A., Maciejewski, Jaroslaw P., Carew, Jennifer S.
Pubblicato in Leukemia (2019)

Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia

di Afable, Manuel G., Shaik, Mohammed, Sugimoto, Yuka, Elson, Paul, Clemente, Michael, Makishima, Hideki, Sekeres, Mikkael A., Lichtin, Alan, Advani, Anjali, Kalaycio, Matt, Tiu, Ramon V., O’Keefe, Christine L., Maciejewski, Jaroslaw P.
Pubblicazione 2011